ReviewHypertension research : official journal of the Japanese Society of Hypertension2018

The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review.

Luciana M A Borém et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.